JAMA Network
What The Study Did: Researchers compared outcomes among high-risk Native American patients who did or didn't receive monoclonal antibody treatment for COVID-19.
Authors: Ryan M. Close, M.D., M.P.H., of Whiteriver Indian Hospital in Whiteriver, Arizona, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2021.25866)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
